These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15368443)

  • 1. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
    McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
    Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
    dela Peña A; Leclercq IA; Williams J; Farrell GC
    J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
    Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
    J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
    Yamazaki Y; Kakizaki S; Horiguchi N; Sohara N; Sato K; Takagi H; Mori M; Negishi M
    Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK; Kim MK; Kim HS; Seo HY; Lee KU; Kim JG; Park KG; Lee IK
    Life Sci; 2012 Jan; 90(5-6):200-5. PubMed ID: 22154902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
    Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
    Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic microcirculation in fatty liver disease.
    Farrell GC; Teoh NC; McCuskey RS
    Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
    Yamazaki Y; Kakizaki S; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
    J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
    Sugimoto H; Okada K; Shoda J; Warabi E; Ishige K; Ueda T; Taguchi K; Yanagawa T; Nakahara A; Hyodo I; Ishii T; Yamamoto M
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G283-94. PubMed ID: 19926817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
    Rangnekar AS; Lammert F; Igolnikov A; Green RM
    Liver Int; 2006 Oct; 26(8):1000-5. PubMed ID: 16953841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
    Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
    Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
    Yu J; Chu ES; Hui AY; Cheung KF; Chan HL; Leung WK; Farrell GC; Sung JJ
    Biochem Biophys Res Commun; 2007 Apr; 356(1):53-9. PubMed ID: 17350593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of apoptosis and the related genes in non-alcoholic steatohepatitis].
    Nan YM; Wu WJ; Yao XX; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):41-6. PubMed ID: 17244458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.